MCHP vs STM vs ALAB
161 measures in 16 categories, one definition each, computed from filings and market data.
MCHP72.1
Microchip Technology Incorporated
Technology · Semiconductors
$73.85 −0.55%$40.1B mkt cap
Score DNA
ALAB77.1
Astera Labs, Inc. Common Stock
Technology · Semiconductors
$285.82 −5.35%$49.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
MCHP STM ALAB · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 9 | 0 | 0 |
| Last Congress purchase | 2026-09-11 | — | — |
| 13F net change in holders | +121 | +216 | +288 |
| ETFs adding shares, 30d | 1,213 | 54 | 1,002 |
| ETFs trimming, 30d | 967 | 41 | 683 |
| Net ETF funds, 30d | +246 | +13 | +319 |
Valuation
16 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| P/E (TTM) | 89.0x
80th
|
87.1x
78th
|
134.2x
92nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | — |
| Price / sales | 7.8x
49th
|
3.1x
20th
|
41.3x
96th
|
| Price / book | 6.2x
56th
|
2.3x
21st
|
28.7x
99th
|
| Price / tangible book | — | 4.3x
15th
|
53.9x
90th
|
| Price / free cash flow | 36.1x
26th
|
187.3x
96th
|
179.2x
94th
|
| Price / operating cash flow | 33.5x
43rd
|
17.9x
17th
|
147.7x
95th
|
| Enterprise value | $45.2B
76th
|
$38.5B
75th
|
$48.3B
77th
|
| EV / sales | 8.8x
56th
|
2.9x
18th
|
40.2x
97th
|
| EV / EBITDA | 26.8x
46th
|
14.4x
18th
|
144.7x
89th
|
| EV / EBIT | 44.8x
60th
|
50.6x
66th
|
150.1x
91st
|
| EV / free cash flow | 40.7x
31st
|
178.0x
96th
|
174.7x
93rd
|
| Earnings yield | 1.1%
45th
|
1.1%
47th
|
0.7%
37th
|
| FCF yield | 2.8%
81st
|
0.5%
31st
|
0.6%
32nd
|
| Operating cash flow yield | 3.0%
67th
|
5.6%
87th
|
0.7%
27th
|
| Graham number (per share) | $14.69
19th
|
$14.64
17th
|
$20.78
27th
|
Profitability (TTM)
12 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Gross margin | 60.2%
83rd
|
34.3%
25th
|
75.1%
92nd
|
| EBITDA margin | 32.9%
78th
|
20.4%
54th
|
27.8%
70th
|
| Operating margin | 15.5%
60th
|
5.2%
41st
|
22.8%
75th
|
| EBIT margin | 19.7%
65th
|
5.8%
42nd
|
26.8%
76th
|
| Net margin | 8.8%
48th
|
3.6%
39th
|
30.7%
88th
|
| NOPAT margin | 12.8%
59th
|
3.4%
39th
|
26.1%
81st
|
| FCF margin | 21.7%
76th
|
1.7%
29th
|
23.0%
80th
|
| Operating cash flow margin | 23.4%
60th
|
17.3%
49th
|
27.9%
80th
|
| R&D / revenue | 22.2%
61st
|
16.1%
45th
|
36.1%
85th
|
| SG&A / revenue | 13.7%
44th
|
12.9%
41st
|
16.2%
57th
|
| Stock comp / revenue | 5.4%
60th
|
— | 16.2%
84th
|
| Effective tax rate | 17.4%
49th
|
35.4%
97th
|
-14.7%
4th
|
Returns on capital
11 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| ROE (on average equity) | 6.8%
49th
|
2.6%
36th
|
25.8%
81st
|
| ROA | 3.1%
43rd
|
1.7%
39th
|
23.1%
89th
|
| ROIC | 5.7%
43rd
|
2.8%
35th
|
66.4%
95th
|
| ROCE | 7.7%
53rd
|
3.4%
37th
|
18.2%
76th
|
| Return on tangible assets | 6.9%
53rd
|
2.8%
39th
|
20.1%
81st
|
| Cash ROIC (OCF / invested capital) | 10.3%
34th
|
14.4%
51st
|
71.0%
97th
|
| Gross profitability (GP / assets) | 21.4%
48th
|
16.6%
28th
|
46.8%
95th
|
| ROIC, 3-yr average | 4.1%
36th
|
6.3%
45th
|
— |
| ROIC, 5-yr average | 8.1%
35th
|
20.5%
60th
|
— |
| ROE, 5-yr average | 17.4%
70th
|
16.4%
62nd
|
— |
| Incremental ROIC | -155.2%
6th
|
22.7%
58th
|
33.7%
65th
|
Growth
17 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Revenue growth (TTM YoY) | 20.9%
58th
|
10.3%
36th
|
98.5%
96th
|
| Revenue growth (QoQ) | 13.2%
51st
|
12.7%
47th
|
27.3%
84th
|
| Revenue CAGR, 3 yr | -16.4%
3rd
|
-8.9%
10th
|
— |
| Revenue CAGR, 5 yr | -2.1%
15th
|
1.9%
29th
|
— |
| Gross profit CAGR, 3 yr | -19.7%
0th
|
-18.8%
2nd
|
— |
| Operating income CAGR, 3 yr | -37.9%
15th
|
-48.1%
2nd
|
— |
| Net income growth (TTM YoY) | — | -37.0%
10th
|
268.9%
85th
|
| Net income CAGR, 3 yr | -42.7%
10th
|
-52.7%
5th
|
— |
| EPS growth (TTM YoY) | — | -39.3%
10th
|
260.5%
85th
|
| EPS CAGR, 3 yr | -42.7%
13th
|
-52.4%
5th
|
— |
| EPS CAGR, 5 yr | -0.7%
32nd
|
-21.9%
17th
|
— |
| FCF growth (TTM YoY) | 53.1%
70th
|
— | 31.5%
52nd
|
| FCF CAGR, 3 yr | -30.4%
20th
|
-49.9%
2nd
|
— |
| Operating cash flow CAGR, 3 yr | -31.8%
10th
|
-27.9%
14th
|
— |
| Book value CAGR, 3 yr | -1.8%
20th
|
7.4%
51st
|
— |
| Dividend CAGR, 3 yr | 3.1%
56th
|
-34.5%
4th
|
— |
| Sustainable growth rate | -9.7%
0th
|
2.1%
19th
|
25.8%
83rd
|
Margin history & stability
7 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Gross margin, 3-yr average | 59.3%
83rd
|
37.3%
29th
|
76.1%
94th
|
| Operating margin, 3-yr average | 15.6%
65th
|
10.7%
55th
|
-15.3%
18th
|
| Net margin, 3-yr average | 8.7%
54th
|
9.8%
56th
|
-7.8%
27th
|
| FCF margin, 3-yr average | 23.2%
80th
|
1.8%
27th
|
26.6%
87th
|
| Revenue stability (0-1) | 0.16
19th
|
0.00
1st
|
0.99
100th
|
| Earnings stability (0-1) | 0.13
35th
|
0.22
42nd
|
0.99
99th
|
| Margin stability (0-1) | 0.92
49th
|
0.84
21st
|
0.98
94th
|
Liquidity (latest quarter)
7 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Cash & short-term investments | $272.3M
25th
|
$6.0B
89th
|
$1.3B
67th
|
| Net cash (− = net debt) | −$5.1B
8th
|
$2.0B
95th
|
$1.3B
87th
|
| Working capital | $1.2B
53rd
|
$8.1B
88th
|
$1.5B
67th
|
| Current ratio | 1.92
15th
|
2.78
35th
|
10.05
91st
|
| Quick ratio | 1.11
3rd
|
2.08
41st
|
9.36
92nd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.21
1st
|
1.32
41st
|
7.63
92nd
|
| Defensive interval (days) | 198 days
1st
|
778 days
49th
|
838 days
53rd
|
Leverage & solvency (latest quarter)
13 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Total debt | $5.4B
87th
|
$4.0B
79th
|
$0
0th
|
| Debt / equity | 0.84
85th
|
0.23
53rd
|
0.00
0th
|
| Net debt / equity | 0.79
97th
|
−0.11
61st
|
−0.73
5th
|
| Debt / assets | 37.5%
85th
|
14.9%
53rd
|
0.0%
0th
|
| Debt / capital | 45.6%
85th
|
18.6%
53rd
|
0.0%
0th
|
| Debt / EBITDA | 3.20
73rd
|
1.51
61st
|
0.00
0th
|
| Net debt / EBITDA | 3.04
93rd
|
−0.75
52nd
|
−3.75
18th
|
| Interest coverage (EBIT / interest) | 4.7x
41st
|
18.6x
63rd
|
— |
| Cash interest coverage | 5.6x
28th
|
55.1x
76th
|
— |
| Debt payback (years of OCF) | 4.5 yrs
84th
|
1.8 yrs
60th
|
0.0 yrs
0th
|
| Liabilities / assets | 55.2%
85th
|
33.2%
55th
|
10.7%
9th
|
| IS credit model rating | A- | AA- | AA |
| Implied credit spread (bps) | 175
56th
|
100
39th
|
80
19th
|
Efficiency
11 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Asset turnover | 0.35
19th
|
0.49
36th
|
0.75
73rd
|
| Fixed asset turnover | 4.72
51st
|
1.20
11th
|
10.08
88th
|
| Inventory turnover | 1.8
15th
|
2.7
49th
|
3.5
79th
|
| Receivables turnover | 6.0
47th
|
7.7
71st
|
11.1
92nd
|
| Days sales outstanding | 61 days
53rd
|
48 days
29th
|
33 days
8th
|
| Days inventory outstanding | 198 days
85th
|
137 days
51st
|
105 days
21st
|
| Days payables outstanding | 35 days
13th
|
68 days
80th
|
52 days
55th
|
| Cash conversion cycle (days) | 224 days
85th
|
116 days
37th
|
86 days
17th
|
| Capex / revenue | 1.7%
11th
|
15.6%
86th
|
4.9%
54th
|
| Capex / depreciation | 0.13
3rd
|
1.07
62nd
|
4.93
96th
|
| Operating expense ratio | 40.6%
69th
|
28.5%
42nd
|
50.5%
77th
|
Cash flow & earnings quality
7 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Operating cash flow / net income | 2.66
79th
|
4.86
92nd
|
0.91
27th
|
| FCF / net income | 2.47
88th
|
0.47
13th
|
0.75
38th
|
| FCF / operating cash flow | 92.7%
89th
|
9.6%
7th
|
82.4%
63rd
|
| Capex / operating cash flow | 7.3%
11th
|
90.4%
93rd
|
17.6%
37th
|
| Accruals ratio | -5.1%
47th
|
-6.7%
33rd
|
2.1%
83rd
|
| Sloan accruals ratio | -7.1%
12th
|
-1.2%
32nd
|
25.1%
79th
|
| Earnings quality score (0-1) | 0.75
15th
|
0.75
15th
|
0.75
15th
|
Scores & forensic checks
15 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| IS score | 72
72nd
|
45
28th
|
77
85th
|
| IS profitability | 53
60th
|
23
32nd
|
94
87th
|
| IS growth | 73
60th
|
29
11th
|
78
79th
|
| IS value | 36
41st
|
49
83rd
|
36
45th
|
| IS momentum | 98
92nd
|
61
32nd
|
89
73rd
|
| IS risk (safety) | 100
12th
|
100
12th
|
100
12th
|
| IS quality | 73
63rd
|
69
48th
|
80
72nd
|
| IS balance sheet | 48
13th
|
95
88th
|
92
72nd
|
| IS earnings quality | 71
76th
|
71
75th
|
70
73rd
|
| IS cash flow | 78
81st
|
38
36th
|
76
79th
|
| Piotroski F-score (0-9) | 6
43rd
|
6
43rd
|
4
9th
|
| Altman Z-score | 4.9
23rd
|
6.2
28th
|
258.9
100th
|
| Beneish M-score | −2.52
40th
|
−2.92
15th
|
2.43
99th
|
| Ohlson O-score | −8.46
72nd
|
−9.88
41st
|
−14.21
5th
|
| IS credit score | 66
32nd
|
84
61st
|
89
72nd
|
Size (TTM)
8 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| Market cap | $40.1B
75th
|
$40.5B
76th
|
$49.6B
77th
|
| Revenue | $5.1B
75th
|
$13.1B
83rd
|
$1.2B
56th
|
| EBITDA | $1.7B
79th
|
$2.7B
81st
|
$334.0M
59th
|
| Net income | $450.6M
72nd
|
$465.0M
73rd
|
$369.5M
68th
|
| Free cash flow | $1.1B
79th
|
$216.3M
61st
|
$276.7M
64th
|
| Total assets | $14.4B
79th
|
$27.0B
87th
|
$1.9B
45th
|
| Shareholders' equity | $6.5B
76th
|
$17.6B
87th
|
$1.7B
55th
|
| Employees | 17,900
79th
|
49,157
95th
|
756
19th
|
Price performance
9 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| 1 day | −0.6% | −2.6% | −5.3% |
| 1 week | −2.2% | −12.8% | −16.5% |
| 1 month | +4.3% | −6.5% | −2.6% |
| 3 months | −7.7% | −26.4% | −7.5% |
| 6 months | −5.2% | +3.0% | +64.2% |
| Year to date | +15.5% | +66.8% | +59.2% |
| 1 year | +16.2% | +58.1% | +77.0% |
| 3 years, cumulative | −1.9% | +3.7% | — |
| 5 years, cumulative | +12.7% | +14.4% | — |
Technicals
4 measures| Measure | MCHP | STM | ALAB |
|---|---|---|---|
| RSI 14 | 45.3 | 32.0 | 37.4 |
| From 52-week high | −29.5% | −44.1% | −42.8% |
| From 52-week low | +56.2% | +117.0% | +192.0% |
| Beta | 1.76 | 1.52 | 3.69 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17